Our interdisciplinary team comprises of experts across medicinal chemistry, cheminformatics, computational biology and machine learning
Dr. Francesco Trozzi, PhD, is a part of Harmonic Discovery's computational chemistry team. Dr. Trozzi received his PhD from SMU where he studied the mechanism of protein allostery in LOV Domains and ACE2 PD via molecular dynamics and machine learning.
Dr. Anna Cichonska, PhD, is Harmonic Discovery's Director of Data Science and Head of European Operations. Dr. Cichonska completed her PhD at Aalto University and the Finnish Institute for Molecular Medicine in computational biology and machine learning. She is an expert in the development of machine learning models to predict kinase-ligand interactions.
Dr. Juhi Somani, PhD, is part of the Computational Biology Team at Harmonic Discovery. Dr. Somani completed her PhD in computational biology at the University of Helsinki and is an expert in transcriptomics and metabolomics.
Dr. Marcel Patek, PhD, is a co-founder and CSO of Harmonic Discovery. Dr. Patek is an industry veteran with over 25+ years of experience in drug discovery. Previously he was the Director of Chemistry at Sanofi and the Vice President of chemistry at ICAGEN.
Dr. Navriti Sahni, PhD, is a part of the Medicinal and Computational Chemistry team at Harmonic Discovery. Dr. Sahni completed her PhD at Punjabi University and has extensive expertise in designing multi-targeted kinase therapeutics.
Dr. Guru Ravikumar, PhD, is Harmonic Discovery's Director of Chemical Informatics. Dr. Ravikumar completed his PhD at the University of Helsinki where he developed several computational chemogenomic approaches to study the polypharmacology of kinase inhibitors.
Dr. Rayees Rahman, PhD, is a co-founder and CEO of Harmonic Discovery. Dr. Rahman completed his PhD at the Icahn School of Medicine at Mount Sinai where he developed machine learning approaches to characterize the 3D structure of protein kinases and their inhibitors.
Dr. Jason Lee, MD, is a co-founder and COO of Harmonic Discovery. Dr. Lee completed his medical training at the Icahn School of Medicine at Mount Sinai. Previously he was a life science investor at OrbiMed, and performed business development duties at Pacira Pharmaceuticals.
Dr. Andreas Bender is leading expert in medicinal chemistry and cheminformatics. Dr. Bender is a Professor of Molecular Informatics at Cambridge University and CSO of Terra Lumina. Previously he was Associate Director of Computational ADME and Safety at AstraZeneca and at co-founder of HealX.
Dr. Oliver Elemento, PhD, is an expert in biomedical data science and systems biology for drug discovery. Dr. Elemento is a Professor of Physiology and Biophysics at Weill Cornell Medicine and the Director of the Englander Institute for Precision Medicine. He is also the founder of venture-backed startups such as Volastra Therapeutics and Onethree Biotech.
Dr. Omar Abdel-Wahab, MD, is an oncologist and expert in blood and solid tumors. Dr. Abdel Wahab is the Chair of Molecular Pharmacology at the Sloan Kettering Institute and Director, MSK Center for Hematologic Malignancies.
Dr. Tero Aittokallio, PhD, is an expert in statistical and predictive drug response modeling. He is professor and group leader at the Institute for Cancer Research at Oslo University Hospital and a group leader at the Institute for Molecular Medicine Finland.
Dr. Joel Dudley is an expert in biomedical data science, computational biology and machine learning. He currently is a partner at Innovation Endeavors. Previously he was Chief Scientific Officer at Tempus Labs, and executive Vice President and Associate Professor at the Mount Sinai School of Medicine. He was also the co-founder of companies such as Onegevity Health and Numedii.
Annalise Schweickart is a PhD student at the Tri-Institutional Computational Biology and Medicine Program at Weill Cornell Medical College.
Carmen Al-Masri is a PhD student in Computational Chemistry at University of California Irvine.
Katalina Biondi is a PhD student in Machine Learning the University of Southern Florida.
Colin Small is a Masters student in Bioinformatics at Brown University.
Dr. Eric Bach, PhD. Completed his PhD at Aalto University in Machine Learning.
Inan Khan is a Masters student in Bioinformatics at New York University.
Yajas Shah is a PhD student in Computational and Systems Biology at Weill Cornell Medical College.
Dr. Yohana Ghebrechristos, PhD completed her PhD in Cancer Biology at New York University.
Jason Lin is a BS student in Chemical Engineering at the University of Michigan Ann Arbor
Dr. Michael Moret, PhD completed his PhD in molecular machine learning at ETH Zurich. He is currently a post-doc at the George Church Lab at Harvard